Showing results (231-240 of 268) with videos related to
Sort By:
Pageof 27
Chemistry & Biodiversity|July 20, 2007
ADME investigations of unnatural peptides: distribution of a 14C-labeled beta 3-octaarginine in ratsH Markus Weiss, Bernard Wirz, Alain Schweitzer, et al.Paediatric Anaesthesia|November 10, 2012
Do lower cuff pressures reduce damage to the tracheal mucosa? A scanning electron microscopy study in neonatal pigsAnnette P N Kutter, Anne G Bittermann, Regula Bettschart-Wolfensberger, et al.Journal of Clinical Gastroenterology|October 17, 2014
Prophylactic Transcatheter Arterial Embolization After Successful Endoscopic Hemostasis in the Management of Bleeding Duodenal UlcerMarkus Mille, Juliane Huber, Rüdiger Wlasak, et al.European Journal of Clinical Pharmacology|October 29, 2020
Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologistsCamille E van Hoorn, Robert B Flint, Justin Skowno, et al.Intensive Care Medicine|February 26, 2008
Cardiac output measurement in children: comparison of the Ultrasound Cardiac Output Monitor with thermodilution cardiac output measurementWalter Knirsch, Oliver Kretschmar, Maren Tomaske, et al.International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
Spot-scanning proton therapy for malignant soft tissue tumors in childhood: First experiences at the Paul Scherrer InstituteBeate Timmermann, Andreas Schuck, Felix Niggli, et al.Paediatric Anaesthesia|December 17, 2004
Tissue oxygenation monitoring during major pediatric surgery using transcutaneous liver near infrared spectroscopyMarkus Weiss, Gabriele Schulz, Ian Teller, et al.Data in Brief|September 23, 2016
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthmaVeit J Erpenbeck, Todor A Popov, David Miller, et al.Clinical Pharmacology in Drug Development|June 17, 2016
Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo-Controlled Studies in Healthy VolunteersVeit J Erpenbeck, Eva Vets, Lien Gheyle, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 4, 2022
Human Pharmacokinetics of LYS006, an Oral Leukotriene A4 Hydrolase Inhibitor Displaying Target-Mediated Drug DispositionBirk Poller, David Pearson, Luc Alexis Leuthold, et al.Pageof 27